View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, Nov. 24 (HealthDay News) -- The use of proton-pump inhibitors (PPIs) by pregnant women in the first trimester to treat the symptoms of gastroesophageal reflux does not significantly increase the risk of major birth defects, according to a study in the Nov. 25 issue of the New England Journal of Medicine.
Björn Pasternak, M.D., and Anders Hviid, of the Statens Serum Institut in Copenhagen, Denmark, and colleagues assembled data from nationwide registries on pregnancies during 1996 to 2008, including maternal exposure to PPIs (from four weeks before conception through the first trimester) and the incidence of major birth defects in children diagnosed in the first year after birth.
There were 5,082 cases of maternal exposure to PPIs among the 840,968 births during the study period. In the PPI-exposed group, the researchers found that there were 174 major birth defects (3.4 percent), compared to 21,811 major birth defects in the non-PPI-exposed group (2.6 percent). For cases in which the PPI exposure occurred within the first trimester, there were 118 major birth defects (3.2 percent).
"In this nationwide cohort study, we found no significant association between the use of PPIs during the first trimester of pregnancy and the risk of major birth defects. These results provide reassurance that PPIs, and omeprazole in particular, can be used relatively safely during the first trimester," the authors conclude.
The editorial author disclosed a financial relationship with Merck.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top